'Totally unfair': Retirement village resident decries $285,000 transfer fee
Consumer NZ says such fees are unfair and mean people often can't shift.
AdvertisementAdvertise with NZME.
Latest from Healthcare
Fisher & Paykel Healthcare ups dividend
Predicted full-year result better than many analysts had been expecting.
Radius expenses push profit down as it brings in nurses from overseas
Company went on a big overseas nursing recruitment drive last year to fully staff places.
Market close: NZ stocks drift as company results fail to inspire
It was another topsy-turvy day for the NZ sharemarket.
Ebos Group's pet project is off, shares fall sharply as trading resumes
Ebos had been in a trading halt since last week.
Crucial talks imminent in Fisher & Paykel Healthcare industrial action
The chances of averting a strike at a major factory hinge on Wednesday's talks.
'Breakthrough': Auckland AI start-up chosen for fast-track approval in the US
A rare honour followed the $13m raise.
Fisher & Paykel Healthcare staff upset at overtime impasse
More than 1500 staff at giant Kiwi firm in dispute over pay, overtime.
Downer profit halves, named as co-defendant in leaky building claim
Revenue rises 26 per cent to $2.7 billion.
Opinion: Localism - the common thread in New Zealand's emerging coalition
OPINION: A solid foundation for the new Government.
Stock Takes: What’s eating Fisher & Paykel Healthcare?
Since June 30, Fisher & Paykel Healthcare's stock has fallen by 14 per cent.
Stock Takes: Synlait’s big reveal, Fisher and Paykel's investor day
More light will be shed on the state of play with cash-strapped Synlait Milk on Monday.
NZ sharemarket holds its ground in face of weaker offshore bourses
The S&P/NZX 50 Index traded steadily, closing slightly lower for the day.
Market close: Tourism Holdings leads way after profit turnaround
The New Zealand sharemarket finished the day higher after a late surge.
Ebos makes record profit despite Chemist Warehouse loss, CEO pay tops $8m
Owner of Animates and medical product distributor made $13 billion in sales.
Ebos profit surges, Seeka faces challenges, SkyCity praises NZ performance
Big players reveal financial performances as corporate results season heats up.
NZ Inc makes big push in India with business delegation
New Zealand will send one of its largest business delegations to India next week.
BlackRock says new $100m-plus stake notice 'administrative error'
Drama from Australia on the day would-be target issues annual result.
Sir Ian Taylor: Chest pains, a hospital visit, and reflections on modern-day NZ
OPINION: No one is offering anything that looks remotely like a vision for health.
Editorial: Still paying for bungled RATs rollout
The Government's delivery of RATs was flawed from the outset.
Jarden Brief: Meta on a Quest for new VR subscription service
VR attempt to curb the recent trajectory of multi-billion operating loss.
'Tour de force' in heritage restoration wins Property Council award
Sensitive refurbishment and amalgamation of the buildings takes prize.
Auckland airport share sale: Ratepayers could end up being short-changed
Council's compromise might have just delivered Aucklanders the worst of two worlds.
$166m expansion at Wellington's biggest private hospital
Full hospital redevelopment 5km south of the city's CBD.
Jarden Brief: Another chipmaker wants a slice of the hot stock action
Nasdaq and Dow Jones down as debt debate starts, but chipmaker upbeat.
Post-Covid reality check? F&P Healthcare profit drops 34pc
F&P Healthcare's earnings have fallen to more normal levels after a big Covid-surge.
Who’s in the running to handle possible Auckland Airport share sale?
Meanwhile, details emerge of Virgin Australia's re-listing plans.
Jarden Brief: Johnson & Johnson down after more fallout from baby powder scandal
Baby powder scandal grows into big, expensive problem for healthcare multinational.
Jarden Brief: Chip war heats up as US-China competition sparks strict new rules
Restrictions part of US effort to impede Beijing’s ambitions while ensuring stable supply.
CEO pay survey revealed: How much NZ’s top bosses get paid
The country’s most powerful bosses have cashed in on the pre-Covid bull market.
Metlifecare pushes up revenue 32% after rising sales, fees
Total sales rose 12 per cent, despite challenges in the housing market.
EBOS Group’s H1 profit hits a record A$141m, lifts dividend
EBOS boom times for healthcare and pet food divisions.
F&P Healthcare shares soar on revenue guidance
Flu season and China Covid outbreak boosts demand.
Market close: NZ stocks rise on back of big Wall St turnaround
An energetic Fisher and Paykel Healthcare led the way.